- Luminex (NASDAQ:LMNX), a maker of covid-19 testing kits, rose 8.5% after a report that that the company is exploring its options after getting takeover interest.
- No final decision has been if the company will go ahead with sale or remain a standalone, according to the Bloomberg report.
- Recall late last month Bloomberg also reported that DiaSorin SpA (OTCPK:DSRLF) was considering an acquisition of Luminex.